Stock screenerAll disclosures →
EDGAR →
BLSM
Conviction 0Scan · Tue, Aug 18, 2026BLSM$16.38+1.24%
ResistanceSupportVol 14Insider buy6
Aug 7Aug 10Aug 11Aug 13Aug 14Aug 17
BlossomHill Therapeutics, Inc.Pharmaceutical Preparations
Price16.38
Change+1.24%
Gap-0.25%
Rel volume0.31×
Avg volume552.75K
Avg $ vol8.92M
SMA 20—
SMA 50—
SMA 200—
Price vs 50—
Price vs 200—
MA stack—
50/200 cross—
Supertrend—
RSI (14)—
MACD hist—
MACD cross—
Stoch %K / %D— / —
ADX (14)—
+DI / −DI— / —
RSI divergence—
MACD divergence—
ATR %—
ADR %—
52w high16.52
52w low15.99
From 52w high-0.85%
Above 52w low+2.44%
New 52w highNo
SqueezeOff
Bollinger width—
%B—
Donchian pos—
Donchian high—
Donchian low—
AVWAP (52w high)16.42
vs AVWAP high-0.25%
AVWAP (52w low)16.12
vs AVWAP low+1.59%
OBV trend—
Chaikin MF (20)—
Today vs 20d0.31×
Avg vol (14d)—
Avg vol (20d)552.75K
Avg $ vol (20d)8.92M
Market cap—
RS 3m (vs SPY)—
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank81.4
1 week+2.44%
1 month—
3 months—
6 months—
1 year—
YTD+2.37%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out—
Employees—
Listed—
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank81.4 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in BLSM
No recent disclosed trades by Congress in BLSM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BLSM · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
GORDON CARL L Director · Common Stock · 2026-08-10 | Convert | 1.04M | — | 2026-08-10 | 2026-08-12 |
GORDON CARL L Director · Common Stock · 2026-08-10 | Convert | 1.05M | — | 2026-08-10 | 2026-08-12 |
GORDON CARL L Director · Common Stock · 2026-08-10 | Buy | 625K | $10M | 2026-08-10 | 2026-08-12 |
GORDON CARL L Director · Series A Preferred Stock · 2026-08-10 | Convert | 1.04M | — | 2026-08-10 | 2026-08-12 |
GORDON CARL L Director · Series B Preferred Stock · 2026-08-10 | Convert | 1.05M | — | 2026-08-10 | 2026-08-12 |
ORBIMED ADVISORS LLC Director · Common Stock · 2026-08-10 | Convert | 1.05M | — | 2026-08-10 | 2026-08-12 |
ORBIMED ADVISORS LLC Director · Common Stock · 2026-08-10 | Buy | 625K | $10M | 2026-08-10 | 2026-08-12 |
ORBIMED ADVISORS LLC Director · Series A Preferred Stock · 2026-08-10 | Convert | 1.04M | — | 2026-08-10 | 2026-08-12 |
ORBIMED ADVISORS LLC Director · Common Stock · 2026-08-10 | Convert | 1.04M | — | 2026-08-10 | 2026-08-12 |
ORBIMED ADVISORS LLC Director · Series B Preferred Stock · 2026-08-10 | Convert | 1.05M | — | 2026-08-10 | 2026-08-12 |
SEC filings
EDGAR filings in BLSM · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.